Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Zanfina Ademi: Routine Lp(a) Testing as a Cost-Effective Step Toward Precision Cardiovascular Prevention
Zanfina Ademi/ LinkedIn
Aug 28, 2025, 19:00

Zanfina Ademi: Routine Lp(a) Testing as a Cost-Effective Step Toward Precision Cardiovascular Prevention

FH Europe Foundation shared an insightful post from Professor Zanfina Ademi on LinkedIn:

“Lp(a): A Missed Opportunity in Cardiovascular Prevention

Despite its strong genetic link to ASCVD and its prevalence in 1 in 5 people, Lp(a) raemains under-tested in clinical practice. A new study in Atherosclerosis highlights both the clinical relevance and cost-effectiveness of routine Lp(a) testing, strengthening the case for its integration into cardiovascular risk assessment.

Led by Monash University, supported by global experts and initiated by FH Europe Foundation, the study shows:

  • Routine Lp(a) testing is cost-saving across multiple health systems
  • It enables earlier intervention with existing therapies
  • It supports value-based care and equitable access to precision prevention

The findings align with the Brussels International Declaration, a 2025 global policy initiative urging governments to include Lp(a) in national cardiovascular screening programs.

Prof. Zanfina Ademi, senior author and health economist at Monash: “From both a public health and economic standpoint, this is a highly cost-effective intervention targeting a major gap in cardiovascular prevention.”

  •  Read the study here:
  •  Endorse the Declaration here:
  •  Share with policymakers and clinical leaders

Zanfina Ademi: Routine Lp(a) Testing as a Cost-Effective Step Toward Precision Cardiovascular Prevention

Stay updated with Hemostasis Today.

ASCVD Atherosclerosis Cardiovascular Prevention Cost-Effectiveness FH Europe Health Hematology Hemostasis Today Lp(a) Medicine Monash University Precision Medicine Public Health Screening Programs Value-Based Care Zanfina Ademi
NewsFeed